Virtual Screening Against Carbohydrate-Binding Proteins: Evaluation and Application to Bacterial Burkholderia ambifaria Lectin.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Ramsland, Paul A
MetadataShow full item record
AbstractBacterial adhesion to human epithelia via lectins constitutes a therapeutic opportunity to prevent infection. Specifically, BambL (the lectin from Burkholderia ambifaria) is implicated in cystic fibrosis, where lectin-mediated bacterial adhesion to fucosylated lung epithelia is suspected to play an important role. We employed structure-based virtual screening to identify inhibitors of BambL-saccharide interaction with potential therapeutic value. To enable such discovery, a virtual screening protocol was iteratively developed via 194 retrospective screening protocols against 4 bacterial lectins (BambL, BC2L-A, FimH, and LecA) with known ligands. Specific attention was given to the rigorous evaluation of retrospective screening, including calculation of analytical errors for enrichment metrics. The developed virtual screening workflow used crystallographic constraints, pharmacophore filters, and a final manual selection step. The protocol was applied to BambL, predicting 15 active compounds from virtual libraries of approximately 7 million compounds. Experimental validation using fluorescence polarization confirmed micromolar inhibitory activity for two compounds, which were further characterized by isothermal titration calorimetry and surface plasmon resonance. Subsequent testing against LecB from Pseudomonas aeruginosa demonstrated binding specificity of one of the hit compounds. This report demonstrates the utility of virtual screening protocols, integrating ligand-based pharmacophore filtering and structure-based constraints, in the search for bacterial lectin inhibitors.
CitationJ Chem Inf Model. 2018 Sep 24;58(9):1976-1989. doi: 10.1021/acs.jcim.8b00185. Epub 2018 Sep 4
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
PublisherAmerican Chemical Society
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Importance of topology for glycocluster binding to Pseudomonas aeruginosa and Burkholderia ambifaria bacterial lectins.
- Authors: Ligeour C, Dupin L, Angeli A, Vergoten G, Vidal S, Meyer A, Souteyrand E, Vasseur JJ, Chevolot Y, Morvan F
- Issue date: 2015 Dec 14
- Synthesis of a selective inhibitor of a fucose binding bacterial lectin from Burkholderia ambifaria.
- Authors: Richichi B, Imberty A, Gillon E, Bosco R, Sutkeviciute I, Fieschi F, Nativi C
- Issue date: 2013 Jun 28
- Fucose-binding lectin from opportunistic pathogen Burkholderia ambifaria binds to both plant and human oligosaccharidic epitopes.
- Authors: Audfray A, Claudinon J, Abounit S, Ruvoën-Clouet N, Larson G, Smith DF, Wimmerová M, Le Pendu J, Römer W, Varrot A, Imberty A
- Issue date: 2012 Feb 3
- Pillararene-Based Glycoclusters: Synthesis and Multivalent Binding to Pathogenic Bacterial Lectins.
- Authors: Buffet K, Nierengarten I, Galanos N, Gillon E, Holler M, Imberty A, Matthews SE, Vidal S, Vincent SP, Nierengarten JF
- Issue date: 2016 Feb 24
- Deciphering the glycan preference of bacterial lectins by glycan array and molecular docking with validation by microcalorimetry and crystallography.
- Authors: Topin J, Arnaud J, Sarkar A, Audfray A, Gillon E, Perez S, Jamet H, Varrot A, Imberty A, Thomas A
- Issue date: 2013